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ABSTRACT 
 Improperly attached kinetochores activate the spindle assembly checkpoint 
(SAC) and by an unknown mechanism catalyze the binding of two checkpoint 
proteins, Mad2 and BubR1, to Cdc20 forming the mitotic checkpoint complex 
(MCC). Here, to address the functional role of Cdc20 kinetochore localization 
in the SAC, we delineate the molecular details of its interaction with 
kinetochores. We find that BubR1 recruits the bulk of Cdc20 to kinetochores 
through its internal Cdc20 binding domain (IC20BD). We show that preventing 
Cdc20 kinetochore localization by removal of the IC20BD has a limited effect 
on the SAC because the IC20BD is also required for efficient SAC silencing. 
Indeed, the IC20BD can disrupt the MCC providing a mechanism for its role in 
SAC silencing. We thus uncover an unexpected dual function of the second 
Cdc20 binding site in BubR1 in promoting both efficient SAC signaling and 
SAC silencing. 
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INTRODUCTION 
Accurate chromosome segregation during mitosis is ensured by the spindle 
assembly checkpoint (SAC), which is a conserved mechanism requiring the 
Aurora B, Mad1, Mad2, Mps1, Bub1, BubR1 (Mad3 in yeast) and Bub3 
proteins1,2. The proper attachment of microtubules to kinetochores is 
monitored by the SAC and a single incorrectly attached kinetochore is able to 
activate the checkpoint3,4. The SAC inhibits chromosome segregation and 
mitotic exit by blocking the degradation of Securin and Cyclin B1, respectively. 
Both of these proteins are targeted for degradation by an E3 ubiquitin ligase, 
the Anaphase Promoting Complex/Cyclosome (APC/C) in complex with its co-
activator Cdc205. APC/C activity is inhibited by the cooperative binding of 
three checkpoint proteins, Mad2, BubR1 and Bub3, to Cdc20, which results in 
the formation of the mitotic checkpoint complex (MCC)6-11. Mad2 can bind 
stably to Cdc20 independently of BubR1 while BubR1 requires Mad2 for its 
stable association with Cdc2012-15. Bub3 does not directly bind to Cdc20 but is 
required for kinetochore recruitment of BubR116-18. Mad2 binds to a short 
conserved sequence in the N-terminus of Cdc20 while BubR1 interacts with 
the WD40 domain of Cdc20 and additional contacts between Mad2 and 
BubR1 stabilize the entire MCC19,20. The protein p31 binds to Mad2 and 
removes it from the MCC leading to sub stoichiometric levels of Mad2 in the 
MCC21. An N-terminal KEN box motif in BubR1 is critical for stable binding to 
Cdc20 and binds to conserved residues on the top side of the WD40 domain 
17,19,22-25. BubR1 in vertebrates also contains an internal Cdc20 binding 
domain (referred to here as IC20BD) that binds the Cdc20 WD40 domain in a 
Mad2 independent manner6,26,27. IC20BD spans residues 490-560 in human 
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BubR1 and binding to Cdc20 depends on a conserved stretch of six amino 
acids within this otherwise poorly conserved part of BubR126. The exact 
function of the IC20BD is not clear but it appears largely dispensable for SAC 
signaling 14,17,28. 
 Cdc20 inhibitory complexes might be assembled at the kinetochore as the 
removal of outer kinetochore proteins inactivates the checkpoint 29. In line with 
this, a small fraction of all checkpoint proteins as well as Cdc20 accumulate at 
unattached kinetochores and turns over rapidly here30-32. Indeed, elegant 
biochemical experiments have shown that kinetochores can stimulate 
complex formation between Mad2 and Cdc2013. Understanding how the 
kinetochore stimulates the binding of checkpoint proteins to Cdc20 is a key 
unresolved question but requires a detailed understanding of how Cdc20 
interacts with kinetochores, which is currently missing. 
 Here, we show that the IC20BD of BubR1 is the major kinetochore receptor 
for Cdc20 and that this domain has dual functions during SAC - both in 
signaling and silencing. We propose that this dual function could couple 
BubR1 localization to MCC production or disassembly. 
 
 
 5 
  
RESULTS  
 
Localization of Cdc20 to kinetochores requires BubR1  
 To understand the mechanism of Cdc20 kinetochore localization, we first 
aimed at identifying the kinetochore receptor during prometaphase. A Cdc20 
monoclonal antibody stained kinetochores and this staining was absent in 
cells depleted of Cdc20 by RNAi showing that it is specific (Supplementary 
Figure 1A). Epitope mapping by peptide array identified an epitope in the N-
terminus of Cdc20 and the antibody could immunoprecipitate MCC 
components (Supplementary Figure 1B-C). We analyzed Cdc20 localization 
as HeLa cells progressed through an unperturbed mitosis and observed that 
the levels were highest in prometaphase at unattached kinetochores and 
decreased in metaphase and anaphase (Supplementary Figure 1D-E). Thus, 
Cdc20 shows the same localization pattern as canonical SAC components as 
expected and argued that Cdc20 was very likely recruited to kinetochores 
through interactions with SAC components. 
 To determine which protein(s) Cdc20 interacts with at the kinetochore, we 
focused on Mad2 and BubR1, as these were obvious candidates. We 
performed RNAi depletion of BubR1 and Mad2 (Figure 1A-C and 
Supplementary Figure 1F for depletion efficiency). The depletion of BubR1 
resulted in a ≈ 65% decrease in Cdc20 kinetochore levels while Mad2 
depletion resulted in an ≈ 35% increase (Figure 1B-C).  
 We used a live cell approach to further investigate the role of Mad2 and 
BubR1 in Cdc20 kinetochore localization. To this end, we generated a stable 
HeLa cell line expressing Venus-Cdc20 (for expression levels see 
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Supplementary Figure 1G), which has previously been shown to complement 
the Cdc20 RNAi phenotype12,33. This cell line and all other cell lines described 
here are stable isogenic inducible cell lines made using a HeLa FRT/TRex cell 
line. When cells expressing Venus-Cdc20 entered mitosis, Cdc20 
accumulated on kinetochores and this signal decreased upon alignment of 
chromosomes (Figure 1D, Supplementary Movie 1). In an unperturbed mitosis 
Cdc20 kinetochore localization depended on BubR1 but not Mad2 (Figure 1D, 
Supplementary Movie 2-3). Quantification of the kinetochore intensity of 
Venus-Cdc20 from the movies revealed similar results as obtained with 
endogenous Cdc20 (Figure 1E). For this analysis we only analyzed cells that 
progressed rapidly through mitosis ensuring that the RNAi against BubR1 and 
Mad2 had worked (see also Supplementary Figure 1H for phenotypic effect of 
Mad2 and BubR1 RNAi). Similar qualitative results were obtained in cells 
treated with nocodazole (Supplementary Figure 1I).  
 Our results reveal a role for BubR1 in the recruitment of Cdc20 to 
kinetochores, similar to that reported in mice and flies27,34. BubR1 appears to 
be a major receptor for Cdc20 at kinetochores but additional receptor(s) likely 
exist as ≈35% Cdc20 remains after very efficient BubR1 depletion. In 
agreement with this, we have found that depletion of KNL1 results in a more 
efficient removal of Cdc20 from kinetochores, which is not due to more 
efficient BubR1 removal from kinetochores (Supplementary Figure 1I). Given 
that BubR1 played a clear role in recruiting Cdc20 to kinetochores, we here 
focus our efforts on understanding the interaction between these two proteins 
at kinetochores. 
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Cdc20 KEN box binding is needed for kinetochore localization 
 The interaction between Cdc20 and BubR1 within the MCC strongly depends 
on binding of the N-terminal KEN box of BubR1 to residues of the WD40 
domain of Cdc2019,25. To determine if this interaction was still required for 
kinetochore localization of Cdc20, we mutated amino acids 377-380 of Cdc20 
to alanine (mutant referred to as Cdc20 4A), as the available Cdc20-BubR1 
structures predict this should disrupt KEN-box binding of Cdc20 (Figure 
2A)19,25.  
 We imaged live cells expressing Venus Cdc20 4A by spinning disk confocal 
microscopy and observed weaker kinetochore localization of Cdc20 4A 
compared to wild type Cdc20 (Figure 2B-C). In contrast, when we mutated the 
Mad2 binding site of Cdc20 by introducing the R132A mutation there was an 
increase in Cdc20 kinetochore levels (Figure 2B-C). These differences were 
not due to differences in the overall expression levels of the different Cdc20 
proteins (Figure 2D). The kinetochore localization pattern of the Cdc20 
mutants was also confirmed by staining the stable cell lines for exogenous 
Cdc20 (Figure 2E) and this is in agreement with the results from our RNAi 
depletion of Mad2 and BubR1 (Figure 1). 
 To ensure that the Cdc20 4A was indeed a functional protein and its inability 
to locate to kinetochores was not due to misfolding, we further analyzed this 
mutant. First, we determined the ability of Cdc20 4A to co-immunoprecipitate 
known interactors from mitotic cells when endogenous Cdc20 was depleted 
(Figure 2 F-G). Cdc20 4A showed a clear reduction in BubR1-Bub3 binding 
but maintained binding to Mad2 as predicted. In agreement with the fission 
yeast MCC structure19, which revealed that BubR1 and p31 compete for the 
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same binding site on Mad2, more p31comet was co-purifying with Cdc20 4A. 
Indeed Mad2 dissociated much more readily from Cdc20 4A when the SAC 
was silenced (Supplementary Figure 2A). As predicted the Cdc20 R132A 
mutant had reduced Mad2 binding but still maintained some binding to 
BubR1-Bub3 although at reduced levels.  
 We next analyzed mitotic progression in stable HeLa cells expressing Venus 
tagged Cdc20, Cdc20 R132A and Cdc20 4A that were depleted of 
endogenous Cdc20. The depletion of Cdc20 delayed cells in mitosis and this 
could be rescued by expressing Venus-Cdc20 (Figure 2H). The expression of 
Cdc20 R132A and Cdc20 4A allowed mitotic progression supporting that the 
mutant proteins were functional and properly folded and this was further 
confirmed by in vitro APC/C ubiquitination assays (Supplementary Figure 2B). 
Furthermore, both Cdc20 R132A and Cdc20 4A progressed faster through 
mitosis (Figure 2H) in agreement with the biochemical analysis showing 
weaker binding to MCC components. As the depletion of Cdc20 by RNAi in 
HeLa cells does not give a robust mitotic arrest, we also analyzed the ability 
of Cdc20 4A to support mitotic progression in mouse embryonic fibroblasts 
(MEFs). We obtained MEFs from the Malumbres lab where exon 2 of Cdc20 
is flanked by loxP sites and can be efficiently removed by Cre recombinase35. 
The MEFs were transfected with the different Venus-Cdc20 constructs 
(human and mouse Cdc20 are almost identical) and removal of endogenous 
Cdc20 was induced by addition of 4-hydroxytamoxifen (4-OHT) 24 hours prior 
to time-lapse imaging. Without the introduction of exogenous Cdc20 there 
was a strong mitotic delay indicative of efficient Cdc20 removal (Figure 2I, 
Supplementary Figure 2C). This was fully suppressed by reintroducing the 
 9 
different forms of Cdc20, showing that Cdc20 4A and Cdc20 R132A are 
functional (Figure 2I, Supplementary Figure 2C). When we challenged the 
MEFs with taxol to activate the SAC, a prolonged mitotic arrest was observed 
when we reintroduced Cdc20 but not Cdc20 R132A and Cdc20 4A confirming 
that these mutants are checkpoint defective (Figure 2I). 
 The analysis of Cdc20 4A reveals that this is a functional protein able to 
interact with Mad2 but defective in stable binding to BubR1-Bub3 and 
therefore unable to support SAC signaling. The failure of Cdc20 4A to 
efficiently locate to kinetochores further supports the role of BubR1 as a 
kinetochore receptor for Cdc20. 
 
The IC20BD of BubR1 recruits Cdc20 to kinetochores 
 Since Cdc20 4A is inefficiently recruited to kinetochores it suggested to us 
that the N-terminal KEN box of BubR1 recruits Cdc20 to kinetochores. To test 
this we generated a panel of stable cell lines expressing inducible Venus 
tagged siRNA resistant BubR1 constructs (Figure 3A). We then depleted 
endogenous BubR1 and induced the expression of exogenous BubR1 and 
treated cells with nocodazole prior to fixation and staining. We stained with a 
BubR1 antibody recognizing an epitope present in all the BubR1 constructs 
assayed and only analyzed cells that had a similar level of BubR1 at 
kinetochores as control treated cells. The kinetochore localization of Cdc20 
could be restored to normal levels by expressing exogenous BubR1 (Figure 
3B-E). Surprisingly, a BubR1 mutant in which the first KEN box was mutated 
to AAA (BubR1 KEN/AAA) also efficiently recruited Cdc20 to kinetochores 
(Figure 3B-E). BubR1 KEN/AAA was clearly defective in forming the MCC as 
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predicted (see Figure 4D). When we compared the ability of BubR1 1-483 and 
BubR1 1-715 in recruiting Cdc20 to kinetochores there was a striking 
difference. BubR1 1-715 clearly recruited Cdc20 while BubR1 1-483 did not 
(Figure 3B-E). The major difference between these two BubR1 constructs is 
that BubR1 1-715 contains the IC20BD. In agreement with this, when we 
deleted the IC20BD of BubR1 (BubR1 Δ490-560), the BubR1-dependent 
kinetochore localization of Cdc20 was lost (Figure 3B-E) indicating that the 
IC20BD and not the N-terminal KEN box of BubR1 recruits Cdc20 to the 
kinetochores. Removal of six conserved residues of the IC20BD (BubR1 
Δ530-535) was enough to prevent Cdc20 kinetochore localization. Both 
BubR1 Δ490-560 and BubR1 Δ530-35 appeared to be folded properly as they 
migrated as wild type BubR1 on a size exclusion column with no signs of 
larger aggregates (Supplementary Figure 3A). Indeed a short peptide 
encompassing this region of BubR1, but not a mutant peptide, could bind 
purified Cdc20 arguing that the loss of Cdc20 kinetochore localization upon 
deletion of the IC20BD is due to loss of a Cdc20 binding site and not 
misfolding of BubR1 (Supplementary Figure 3B). In agreement with this a 
fragment of BubR1 encompasing the IC20BD could recruit Cdc20 to 
kinetochores (Supplementary Figure 3C). Upon overexpression 
(approximately 300-fold endogenous levels) of Venus tagged BubR1 proteins 
encompassing the IC20BD in HEK293 cells, we could detect Cdc20 binding 
confirming previous observations (Supplementary Figure 3 D-E)26,27. However 
at endogenous levels, IC20BD-containing BubR1 fragments do not co-purify 
detectable levels of Cdc20 (data not shown). This could either be due to a 
weak interaction that is not maintained during our purification conditions or 
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that only a small fraction of BubR1 is interacting with Cdc20 through its 
IC20BD. 
  
KEN-box binding residues of Cdc20 binds the IC20BD 
 Initially, we had hypothesized that the defect in kinetochore localization of 
Cdc20 4A was due to its inability to bind the N-terminal KEN box of BubR1. 
However, given our observation that BubR1 KEN/AAA still recruited Cdc20 to 
kinetochores this result was inconsistent with this model. We reasoned that 
possibly the same residues of Cdc20 binding to the N-terminal KEN-box of 
BubR1 are also required for binding to IC20BD even though the IC20BD does 
not contain a KEN-box motif. 
 To test this hypothesis, we expressed Cdc20 and Cdc20 4A in HEK293 cells 
and purified the proteins using a strep-tag. We then compared the ability of 
the Cdc20 proteins to bind a recombinant FLAG tagged fragment of BubR1 
(amino acids 516-715) that encompasses the conserved residues of the 
IC20BD that we found necessary for Cdc20 kinetochore recruitment. The 
BubR1 fragment was first bound to beads using its FLAG tag, next purified 
Cdc20 and Cdc20 4A were titrated in and following incubation, the beads 
were washed. Proteins bound to the beads were analyzed by both 
quantitative western blotting and by coomassie staining (Figure 3F-G and 
Supplementary Figure 3F). From these experiments, it was clear that Cdc20 
bound BubR1 516-715 while this binding was strongly reduced in Cdc20 4A 
explaining its reduced kinetochore localization.  
 
Cdc20 kinetochore localization facilitates SAC signaling 
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  As the IC20BD of BubR1 was required for kinetochore localization of Cdc20, 
we anticipated that it could contribute to SAC signaling although previous 
work has shown that the N-terminal half of BubR1 is largely sufficient for a 
functional SAC 14,17,27. 
 To analyze the function of IC20BD, we compared mitotic progression in 
stable cell lines depleted of endogenous BubR1 and complemented with 
either Venus-BubR1 or Venus-BubR1 Δ490-560 at close to endogenous 
levels (Figure 4A-B, Supplementary Figure 4A). We only analyzed cells with 
comparable levels of BubR1 as judged from the intensity of the Venus signal. 
In an unperturbed mitosis, we did not observe any effect on mitotic 
progression when we removed residues 490-560 (Figure 4A-B). We then 
challenged the cells with either taxol or nocodazole and monitored the length 
of mitotic arrest (Figure 4C). In agreement with previous reports, taxol-
arrested cells had very few or no Mad2 positive kinetochores while all 
kinetochores in nocodazole arrested cells were Mad2 positive (Supplementary 
Figure 4B). In nocodazole-arrested cells, the median time of arrest was only 
slightly reduced in BubR1 Δ490-560 complemented cells  (BubR1 t=405 min., 
BubR1 Δ490-560 t=370 min.) but this was not statistically significant. In taxol-
arrested cells, the length of mitotic arrest was significantly lower in BubR1 
Δ490-560 (BubR1 t=430 min., BubR1 Δ490-560 t=325 min., p≤0.01) but MCC 
formation was not detectably affected, likely reflecting that the biochemical 
assay is less sensitive in detecting small differences in MCC composition 
(Figure 4D). A similar result was obtained with BubR1 Δ530-535 in taxol 
(Supplementary Figure 4C). Since the effect that we saw could be due either 
to the impaired binding of Cdc20 to the IC20BD of BubR1 or to Cdc20 
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impaired localization to the kinetochore, we prevented BubR1 kinetochore 
localization by mutating the Bub3 binding site in BubR1 (BubR1 
E412K/E413K) and BubR1 Δ490-560 (referred to as BubR1 ΔBub3 and 
BubR1 ΔBub3/Δ490-560) which strongly reduced SAC strength (Figure 4E). 
In this situation, we exclude the effect of BubR1 kinetochore localization and 
thereby also of Cdc20, so we can assess the importance of Cdc20 binding 
alone. The duration of a taxol induced mitotic arrest was the same in BubR1 
ΔBub3 and BubR1 ΔBub3/Δ490-560 complemented cells suggesting that it is 
not the binding of Cdc20 to IC20BD but the kinetochore localization of Cdc20 
that contributes to SAC signaling in taxol (Figure 4E). Our results therefore 
suggest that Cdc20 kinetochore localization by the IC20BD contributes to 
SAC signaling under conditions where Mad2 kinetochore levels are low likely 
by facilitating Mad2-Cdc20 complex formation. In agreement with this 
hypothesis, depletion of p31comet, which stabilizes the Mad2-Cdc20 complex, 
resulted in similar timing of BubR1 and BubR1 Δ490-560 in taxol treated cells 
(Figure 4F). 
 
The IC20BD is required for SAC silencing 
 
 Our analysis of the IC20BD reveals that it makes a small contribution to SAC 
signaling despite being critical for Cdc20 kinetochore localization. This was 
puzzling as BubR1 kinetochore localization was critical for an efficient SAC 
(Figure 4E and17). However, we observed that in an unperturbed mitosis 
BubR1 ΔBub3/Δ490-560 complemented cells spent longer time in mitosis 
than BubR1 ΔBub3 (BubR1 ΔBub3/Δ490-560 t=67.5 min, BubR1 ΔBub3 t=50 
min, Mann-Whitney test p≤0.0001) (Figure 5A). Thus, under conditions where 
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the SAC is weakened and MCC production lower, the IC20BD seemed 
important for cells to exit mitosis and thus had the opposite effect than 
observed in the taxol and nocodazole challenge experiments. This pointed to 
a role of the IC20BD in SAC silencing. 
 To directly test this, we challenged BubR1 and BubR1 Δ490-560 
complemented cells with nocodazole and then treated them with reversine to 
silence the SAC and monitored time of exit by live cell microscopy (Figure 5B-
C). This revealed a clear role for the IC20BD in mediating efficient exit in that 
BubR1 exited with a median time of 36.7 min while BubR1 Δ490-560 took 
50.9 min.  
 Given that both the BubR1 N-terminus and the IC20BD required the KEN box 
binding residues of Cdc20 for interaction, a possibility was that the IC20BD 
could facilitate SAC silencing through competition. To test this, we asked 
whether recombinant BubR1 516-715 could dissociate BubR1 from the MCC. 
Using a GFP affinity resin, we purified Venus-Cdc20 from nocodazole-
arrested cells, which co-purified Mad2 and BubR1 (Figure 5D). As previously 
discussed for Venus-BubR1, at close to endogenous levels of proteins we 
cannot detect binding to the IC20BD, arguing that what we purify with Venus-
Cdc20 is a mix of checkpoint complexes (Mad2-Cdc20-BubR1-Bub3, Cdc20-
BubR1-Bub3 and Mad2-Cdc20). Next, we added increasing concentrations of 
recombinant BubR1 516-715 to our affinity purified Venus-Cdc20. Following a 
one hour incubation at room temperature, the beads were washed and the 
amount of MCC components remaining bound to Cdc20 analyzed by 
quantitative western blotting (Figure 5 D-E). With increasing concentrations of 
BubR1 516-715, we observed a gradual reduction of endogenous BubR1 
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bound to Cdc20 while the Mad2 levels were only slightly affected. In 
agreement with this when we overexpressed BubR1 fragments containing the 
IC20BD, but lacking their Bub3 binding site, the SAC was weakened in taxol 
arrested cells. Importantly effective weakening of the SAC depended on the 
conserved residues of the IC20BD (Figure 5F).  
 Our results show that the IC20BD of BubR1 is required for efficient SAC 
silencing and a possible mechanism is by competing with the Mad3 homology 
region of BubR1 for binding to Cdc20.  
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DISCUSSION 
  Here, we have dissected the major mechanism of Cdc20 kinetochore 
recruitment and show that this requires the IC20BD of BubR1 and KEN box 
binding residues of Cdc20. Preventing Cdc20 kinetochore localization by 
removing the IC20BD has a limited effect on the SAC but as the IC20BD is 
also required for SAC silencing these activities of the IC20BD are 
antagonizing each other potentially to make the checkpoint dynamic and 
responsive to BubR1 localization. 
 Our finding that BubR1 is the major kinetochore receptor for Cdc20 in human 
cells, and that this in turn requires the internal Cdc20 binding site of BubR1, is 
in agreement with a number of previous observations. Firstly, a clear role for 
BubR1 but not Mad2 in recruiting Cdc20 to kinetochores has been observed 
in flies and in mice27,34 and fits with the temporal order of recruitment of 
BubR1 and Cdc2036. Secondly, removal of the Mad2 binding site from Cdc20 
does not prevent its kinetochore localization in PtK2 and LLC-PK1 cells similar 
to what we observe in human cells with Cdc20 R132A30,31. As the binding 
between Cdc20 and IC20BD does not require Mad2 binding to Cdc206,26, our 
data explains why Mad2 is not needed for bulk Cdc20 recruitment. Elegant 
FRAP studies of Cdc20 in PtK2 cells revealed two equal sized populations of 
Cdc20 at kinetochores, one with a fast turnover and one with a slower 
turnover30. The Cdc20 population with a slower turnover was dependent on 
the N-terminus of Cdc20 and an active SAC. The same study also detected 
two populations of BubR1 with similar slow and fast turnover as Cdc20. These 
data together with the data presented here suggests that Cdc20 is binding the 
IC20BD of both a slow and a fast pool of BubR1 at kinetochores and that the 
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slow BubR1 pool depends on an active SAC (Figure 6). In flies there appears 
to be only a fast pool of Cdc20 which might reflect a difference in how BubR1 
interacts with kinetochores34,37.  
  Collectively our data does not support that Cdc20 exists in MCC-like 
complexes at kinetochores as both preventing Mad2 binding or mutating the 
N-terminal KEN box of BubR1 did not affect Cdc20 localization. This suggests 
that the full assembly of the MCC occurs in the cytoplasm either through 
maturation of a partly assembled MCC or binding of soluble BubR1 to Mad2-
Cdc20 (Figure 6). 
 Although we find that BubR1 recruits the bulk of Cdc20 to kinetochores our 
work also suggests that at least one other binding partner must exist at 
kinetochores as even after efficient BubR1 depletion ≈35% Cdc20 remains. 
The stronger effect of KNL1 RNAi could point to a role of Bub1 as an 
additional binding partner for Cdc20 at kinetochores and indeed human Bub1 
has been shown to bind Cdc20 (Kang et al., 2007). Further experiments are 
needed to address the role of Bub1 in BubR1 and Cdc20 kinetochore 
localization. 
  The exact function of the IC20BD of BubR1 has not been clear and several 
studies have shown that it is not required for a functional SAC14,17. In the 
study from the Cleveland lab it was however noted that cells complemented 
with full length BubR1 maintained a nocodazole induced arrest for longer time 
than cells complemented with BubR1 1-477 potentially revealing a role of the 
C-terminal half of BubR1 in prolonged arrest14. Although the IC20BD can 
inhibit Cdc20 activity in vitro6, our work and that of others indicate that in vivo 
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the interaction of Cdc20 with this region of BubR1 is either of low affinity or 
restricted to binding a small proportion of Cdc20.  
 Our comparison of BubR1 and BubR1 deleted of its IC20BD only revealed a 
small contribution of this domain to SAC signaling specifically in taxol-arrested 
cells. We favor that the function of the IC20BD is to weakly bind and hereby 
concentrate Cdc20 at kinetochores bringing it in proximity of the Mad1-Mad2 
complex to facilitate Mad2-Cdc20 complex formation. The reason we favor 
this is that we only see a SAC defect when Mad2 signaling from kinetochores 
is low and this defect is suppressed by p31comet removal. Furthermore the 
defect must relate to Cdc20 kinetochore localization as preventing BubR1 
kinetochore localization abolishes the effect of removing the IC20BD. 
However we cannot exclude that the IC20BD plays a more active role in the 
SAC.   
 We also find a requirement of the IC20BD in SAC silencing and the true 
effect on the SAC upon removal of the IC20BD is likely masked by this 
function. We roughly estimate the median times to be 50 min for BubR1 and 
30 min for BubR1 Δ490-560 in an unperturbed mitosis without the effect of the 
IC20BD on SAC silencing. This is as severe an effect on the SAC as mutating 
the Bub3 binding site in BubR1. Our data would support a model in which the 
IC20BD contributes to SAC signaling by recruiting Cdc20 to kinetochores to 
facilitate interaction with Mad2 and in SAC silencing by destabilizing the 
BubR1-Cdc20 interaction within the MCC through competition (Figure 6). As 
these two activities of the IC20BD are counteracting each other, it depends on 
the experimental conditions what activity is the most dominant. This would 
explain why we only see a clear effect on the SAC in taxol arrested cells 
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where the role of the IC20BD in recruiting Cdc20 to kinetochores becomes 
very critical. 
 BubR1 is recruited to improperly attached kinetochores and thus its function 
in recruiting Cdc20 to the kinetochore to facilitate interaction with Mad2 and at 
the same time recruiting PP2A38-40 to stabilize kinetochore-microtubule 
interactions shows the remarkable ability of BubR1 to integrate important 
kinetochore activities through short interaction motifs. Once proper 
kinetochore-microtubule interactions are established BubR1 leaves the 
kinetochore and the IC20BD then acts to destabilize the MCC for efficient 
mitotic exit. The dual function of the IC20BD thus elegantly couples SAC 
signaling or silencing to the localization of BubR1. 
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METHODS 
Cloning and stable cell lines 
 All constructs were cloned into pcDNA5/FRT/TO FLAG Venus (N-terminal 
tagging). Cdc20 and BubR1 and fragments thereof were amplified by PCR 
and inserted into the BamHI and NotI sites of the vector using the primers 
specified in Supplementary table I. Mutations into these constructs were done 
using whole plasmid PCR or 2-step PCR. All constructs were verified by 
sequencing. 
 The generation of stable HeLa cell lines was done using the Flp-In system 
(Invitrogen) and the resulting clones were kept under selection by 
supplementing the growth media with 200 μg/ml Hygromycin B and 5 μg/ml 
Blasticidin S. 
 
Antibodies 
The following antibodies were used for western blot, immunofluorescence or 
immunoprecipitation as indicated: α-tubulin 11H10 (rabbit, Cell Signaling) 
1:100 IF, β-actin AC-15 (mouse, Abcam) 1:5000 WB, APC1 A301-653A 
(rabbit, Bethyl) 1:500 WB, APC3 35/CDC27 (mouse, BD Biosciences) 1:250 
WB, APC4 (mouse, raised against a C-terminal peptide) 5μg IP, APC7 A302-
551A (rabbit, Bethyl) 1:1000 WB, Bub3 clone 31 (mouse, BD Transduction 
Laboratories) 1:500 WB, BubR1 A300-995A (rabbit, Bethyl) 1:500 WB, BubR1 
A300-386A (rabbit, Bethyl) 1:200 IF, Cdc20 AR12 (mouse, Millipore) 1:200 
IF/5 μg IP, Cdc20 E-7 (mouse, Santa Cruz Biotechnology) 1:500 WB, Cdc20 
A301-180A (rabbit, Bethyl) 1:1000 WB, CREST (human, Antibodies Inc.) 
1:400 IF, FLAG M2 (mouse, Sigma) 1:5000 WB, GFP clones 7.1 and 13.1 
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(mouse, Roche) 1:5000 WB /1:200 IF, Mad2 from G. Kops (rabbit) 1:200 IF, 
Mad2 A300-301A (rabbit, Bethyl) 1:1000 WB, p31 rabbit antibody was 
generated using full-length p31 as antigen and affinity purified. 
 
RNAi depletion of proteins 
RNAi depletion of proteins was performed for 48 hours, except for p31 that 
was performed twice at 72 and 48 hours before analysis. DMEM media was 
replaced with OPTIMEM media right before adding a mix containing 100 nM 
RNAi oligo (Sigma) and 4 ul/ml RNAimax (Invitrogen) diluted in OPTIMEM. 
The media was changed after 5 hours and replaced with DMEM 
supplemented with 10% FBS. siRNAs used are: BubR1 5’-
GAUGGUGAAUUGUGGAAUA-3’; Cdc20 5’-
CGGAAGACCUGCCGUUACAUU-3’; KNL1 5’-
AAGAUCUGAUUAAGGAUCCACGAAA-3’; Luciferase 5’-
CGUACGCGGAAUACUUCGA-3’; Mad2 5’-GGAAGAGUCGGGACCACAG-3’; 
p31 5’-GGCUGCUGUCAGUUUACUU-3’ 
 
Immunofluorescence analysis 
For immunofluorescence microscopy, cells were synchronized with 2.5 mM 
thymidine, 10 μM MG132 and 660 mM nocodazole as shown in figure 1A. 
Cells were pre-fixed with 4% PFA in PHEM buffer (50 mM Pipes, 25mM 
Hepes, 10 mM EGTA, 8.5 mM MgSO4, pH 7.0) for 20 seconds, permeabilized 
in 0.5% TritonX-100 in PHEM buffer for 5 minutes and fixed in 4% PFA in 
PHEM buffer for 20 minutes. Coverslips were quenched with 25 mM Glycin in 
PBS for 20 minutes, blocked with 3% BSA in PBS-T (0.1% Tween in PBS) for 
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30 minutes, incubated with primary antibodies for 1 hour, with Alexa Fluor 
goat secondary antibodies for 45 minutes and mounted on slides using 
ProLong Gold Antifade mounting media (Invitrogen).  
Images were acquired taking z stacks of 200 nm using a 100X/1.4NA 
objective on a DeltaVision Elite Microscope (GE Healthcare). Images were 
analyzed after deconvolution using SoftWoRx (GE Healthcare). Figures were 
generated by maximum intensity projection of entire cells using Softworx and 
ImageJ. 
 
Live cell imaging 
Live cell analysis was performed on a Deltavision Elite system using a 40x or 
60x objective (GE Healthcare). Cells were seeded in 8 well Ibidi dishes (Ibidi) 
in advance and prior to filming the media was changed to Leibovitz´s L-15 
(Life technologies). Appropriate channels were recorded for 18 hours and 
data analyzed using Softworx (GE Healthcare). MEFs were transfected with 
Venus-Cdc20 proteins by electroporation using the Neon Transfection System 
according to manufacturer instructions. 1 μM 4-OHT and 200 nM taxol were 
added where indicated 24 hours and 2 hours before filming respectively. For 
experiments in figure 2B images were acquired on a Perkin Elmer UltraView 
Vox-Spinning Disk CSU-X1 using a 60x1.4 oil objective. 
 
Immunopurification of complexes  
Immunoprecipitation of Venus proteins from stable HeLa cell lines was 
performed from cells synchronized with 2.5 mM thymidine and arrested in 
mitosis with either 660 mM nocodazole or 200 mM taxol. The mitotic cells 
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were harvested by shake off, washed with ice-cold PBS and lysed for 30 
minutes on ice in lysis buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.5, 1 mM 
EDTA, 1% NP40, 1 mM DTT, 1x protease inhibitor cocktail (Roche), 1x 
phosphatase inhibitor cocktail (Roche)). Lysates were clarified by 
centrifugation at 20,000 rcf at 4°C for 15 minutes and the resulting cell 
extracts were incubated with 20 μl of GFP-Trap A beads (ChromoTek) at 4°C 
with gentle agitation for 30 minutes. The beads were than washed 3 times 
with ice-cold lysis buffer and the complexes eluted in 2x SDS sample buffer. 
Low salt/high salt IP was performed using a different lysis buffer (50 mM 
NaCl, 25 mM Tris-HCl pH 7.5, 0.1% NP40, 1 mM DTT, 1x protease inhibitor 
cocktail (Roche), 1x phosphatase inhibitor cocktail (Roche)) and washing 
buffer (50 mM Tris-HCl pH 7.5, 1 mg/ml BSA, 20% glycerol, 0.5 mM DTT, 1x 
protease inhibitor cocktail (Roche), 1x phosphatase inhibitor cocktail (Roche)) 
supplemented with 300 mM NaCl only for the high salt condition. IP of 
endogenous proteins was performed using Dynabeads Protein G (Invitrogen) 
and 5 μg of antibodies.  
 
In vitro binding experiments with BubR1 and Cdc20. 
FLAG-HA-BubR1 516-715 was expressed in the E. coli BL21 Rosetta2 (DE3) 
R3 T1 strain by induction with 0.5 mM IPTG for 20 hours at 18°C. The 
bacterial pellet was resuspended in buffer L (50 mM NaP, 300 mM NaCl, 10% 
glycerol, 0.5 mM TCEP, protease inhibitors) and lysed using a high-pressure 
homogenizer at 1,000 Bar. After clarification by centrifugation (18,000 g for 30 
minutes) the protein was purified by affinity (1 ml Ni column (GE healthcare), 
loaded in buffer L with 10 mM imidazole) and gel filtration chromatography 
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(Superdex 200 PG 16/60 equilibrated with SEC buffer (50 mM NaP, 150 
NaCl, 0.5 mM TCEP, 10% glycerol, pH 7.5)). Strep-His-Cdc20 and mutants 
thereof where expressed in HEK293 6E cell lines by transfection with 100 
μg/ml Polyethylenimine “MAX”(PEI) (polysciences). After 3 days the Cdc20 
proteins were affinity purified using a Strep-tag/Strep-Tactin purification 
system (IBA) according to manufactures description. 10 μg of FLAG-HA-
BubR1 516-715 protein was incubated with 20 μl of anti-FLAG M2 affinity gel 
(Sigma) in PBS for 1 hour at room temperature with gentle mixing followed by 
3 washes with washing buffer (PBS, 0.1% TritonX-100). The affinity gel was 
then resuspended in binding buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.5, 
0.3% Triton X-100, 1x protease inhibitor cocktail (Roche), 1x phosphatase 
inhibitor cocktail (Roche)) and incubated with 2, 5 or 10 μg of Strep-His-
Cdc20 proteins for 1 hour at room temperature with gentle mixing. After 4 
washes with the binding buffer the bound proteins were released from the 
affinity gel by addition of 2x SDS sample buffer and incubation at 95°C. The 
eluates were analyzed by Coomassie staining and western blotting against 
BubR1 (FLAG) and Cdc20 (E7, Santa Cruz). 
 
In vitro ubiquitination assays with APC/C. 
 APC/C-Cdc20 complexes were purified from mitotic cells using an APC4 
antibody. Cells where either control treated or depleted of Cdc20 by RNAi and 
the expression of the different Venus-Cdc20 proteins induced by doxycycline. 
In vitro ubiquitination assays with in vitro translated Cyclin B1 1-86 was 
carried out as previously described 41. 
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Binding experiments in HEK293 cells. 
For experiments presented in Figure S3A-B HEK293T cell were transfected 
with Venus-BubR1 proteins and depleted of endogenous BubR1 using 
Lipofectamine 2000 (Invitrogen), 500 ng/ml plasmid and 100 nM RNAi oligo. 
Cells were subsequently synchronized with 2.5 mM thymidine for 24 hours 
and treated with 200 ng/ml nocodazole after the thymidine release. 10 μM 
MG132 was added after 6 hours from the thymidine release for 3 hours. Cells 
were then harvested and washed with ice-cold PBS.    
 
Peptide binding experiments. 
Two peptides were used for this assay: Biotin-YSVPFSIFDEFLLSEKKNKS 
(WT peptide) and Biotin-YSVPFSIAKKAAASEKKNKS (mut peptide) 
(BIOSYNTAN). 2 μg of purified Strep-His-Cdc20 was incubated with peptide-
streptavidin agarose complex (Sigma) for 1 hour at room temperature. The 
binding buffer contains 50 mM Tris-HCl, pH= 7.5, 150 mM NaCl, 0.3% 
TritonX-100 with protease inhibitors. After 4 times of washing with the binding 
buffer, the bound proteins were eluted by 1x Laemmli buffer and released by 
incubating at 95°C. The eluates were analyzed by western blot against Cdc20 
(E7, Santa Cruz). 
 
Size exclusion chromatography.  
 Cell lines were arrested in nocodazole and treated for 1 hour with reversine 
and MG132 before harvesting. The cells were resuspended in lysis buffer 
(150 nM NaCl, 25 mM TRIS pH 8.0, 0.1% NP-40, 1 mM DTT, 1x protease 
inhibitor cocktail (Roche) and 1x phosphatase inhibitor cocktail (Roche)). 
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Following lysis the extract was clarified by spinning for 10 minutes at 20000 g 
and subsequently for 10 minutes at 186000 g in a TLA-55 rotor (Beckman-
Coulter). 500 ul extract at 6 ug/ul was loaded on a Superose 6 10/300 GL 
column equilibrated with lysis buffer. 500 ul fractions where collected and 
analyzed. 
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FIGURE LEGENDS 
Figure 1. Recruitment of Cdc20 to kinetochores requires BubR1. 
A) Schematic of protocol used to synchronize cells and deplete specific 
proteins using RNAi. B) Cells depleted of the indicated proteins were stained 
for CREST and Cdc20 and BubR1 or Mad2 to check for depletion efficiency. 
Scale bar represents 5 μm. C) Quantification of Cdc20, BubR1 and Mad2 
kinetochore levels in cells treated with the indicated RNAi oligoes. The 
fluorescence from the three z-stacks (200 nm apart) encompassing the bulk 
kinetochore fluorescent intensity was used and normalized to the CREST 
signal. Cells were co-stained for Mad2 or BubR1 to ensure that only cells with 
efficient depletion were analyzed. At least 80 kinetochore pairs from 8 cells 
were quantified and the mean and standard error of mean is indicated. D) 
Stable HeLa cell line expressing Venus-Cdc20 was treated with the indicated 
RNAi oligoes and the localization of Venus-Cdc20 followed by time-lapse 
microscopy. Scale bar represents 10 μm. E) Quantification of Venus-Cdc20 at 
kinetochores in the movies in D). The signal was quantified from a single z-
section and in the frame right after NEBD. A total number of 50 kinetochores 
from 10 cells where analyzed for each condition and the mean and standard 
error of mean indicated. An unpaired t-test was performed for statistical 
analysis (**** is p<0.0001) and the comparison is to the control treated cells. 
 
Figure 2. A novel Cdc20 mutant specifically defective in BubR1 binding. 
A) The structure of human Cdc20 bound to the BubR1 KEN-box motif (blue) 
(PDB: 4GGD) with the residues mutated in Cdc20 4A in red. B) Stable HeLa 
cell lines expressing the indicated Cdc20 proteins were analyzed by live cell 
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spinning disk confocal microscopy and representative still images are shown. 
Scale bar represents 10 μm. C) Quantification of Cdc20 intensity at the 
kinetochores from the experiment shown in B). A total of 50 kinetochores from 
10 different cells were analyzed for each condition. Cdc20 kinetochore signal 
was determined using the ImageJ software and mean and standard error of 
mean are shown. An unpaired t-test was used for statistical analysis. (**** is 
p<0.0001). D) The Cdc20 intensity in the cytoplasm was measured from the 
images acquired with the spinning disk from the 10 cells used for the analysis 
in C). An unpaired t-test was used for statistical analysis. E) Stable HeLa cell 
lines expressing the indicated Cdc20 proteins were arrested by nocodazole 
and MG132, and stained for CREST and Cdc20 using a GFP specific 
antibody. Scale bar represents 5 μm. F) Stable HeLa cell lines expressing the 
indicated Cdc20 proteins were arrested in nocodazole and MG132 and cells 
collected by mitotic shake-off. Venus-Cdc20 proteins were purified using a 
GFP affinity resin and washed with either a low salt buffer or high salt buffer 
as indicated. The composition of proteins associated with Cdc20 was 
determined by blotting for the indicated proteins. G) Quantification of the 
proteins bound to Venus-Cdc20 proteins was determined. The mean and 
standard error of means of two independent experiments are shown. H) 
Stable HeLa cells were treated with a control RNAi oligo (Luciferase) or 
depleted of Cdc20 and then complemented with the different Venus-Cdc20 
proteins as indicated. Each circle represents a single cell analyzed (at least 
60 cells were analyzed for each condition) and the red line indicates the 
median (m=). A Mann-Whitney test was performed for statistical analysis. I) 
Mouse embryonic fibroblasts (MEFs) were depleted of Cdc20 by addition of 4-
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OHT 24 hours prior to imaging and complemented with the indicated Venus-
Cdc20 proteins. At least 25 cells were analyzed per condition and a Mann 
Whitney test was used for statistical analysis. Median time (m=) is indicated 
for each condition. 
 
Figure 3. The internal Cdc20 binding site of BubR1 recruits Cdc20 to 
kinetochores. 
A) Schematic of human BubR1 and the location of Cdc20 binding sites and 
Bub3 binding site as well as the pseudo-kinase domain. Alignment of the 
region encompassing residues 530-535 of human BubR1 is shown on top and 
the different constructs used are indicated below. The BubR1 KEN/AAA has 
the first KEN-box mutated to AAA. B) Stable HeLa cell lines expressing the 
different Venus-BubR1 siRNA resistant constructs were used to determine the 
domains in BubR1 required for Cdc20 kinetochore localization. Briefly, cells 
were treated with a control RNAi oligo (Luciferase) or a BubR1 RNAi oligo and 
then arrested in mitosis using nocodazole treatment and the proteasome 
inhibitor, MG132.  BubR1 RNAi treated cells were complemented with the 
indicated Venus-BubR1 constructs. Cells were stained for BubR1, CREST 
and Cdc20. Scale bar represents 5 μm C-D). The kinetochore levels of BubR1 
(C) and Cdc20 (D) normalized to CREST in control and BubR1 depleted cells. 
At least 80 kinetochore pairs from 8 different cells were analyzed and the 
mean and standard error of mean is indicated. E) The level of Cdc20 at 
kinetochores in cells complemented with the indicated Venus-BubR1 
constructs was determined. Only cells with endogenous levels of BubR1 at 
kinetochores were used for this analysis. At least 80 kinetochore pairs from 8 
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different cells were analyzed and the mean and standard error of mean is 
indicated. F) Binding of Cdc20 and Cdc20 4A to BubR1 516-715 was 
determined by binding 10 μg recombinant FLAG-HA-BubR1 516-715 to FLAG 
affinity beads and incubating these with increasing concentrations of Strep-
His tagged Cdc20 or Cdc20 4A expressed and purified from HEK293 cells. 
The beads were washed and bound proteins were eluted and analyzed by 
western blot. G) Quantification of western blot in F) using Licor technology. 
Experiment in F-G is representative of two independent experiments.  
 
Figure 4. The internal Cdc20 binding site of BubR1 contributes to SAC 
signaling during a taxol-induced arrest. 
A) Mitotic progression in HeLa cells stably expressing similar levels of Venus-
BubR1 or Venus-BubR1 Δ490-560 and depleted of endogenous BubR1 was 
determined by time-lapse microscopy. This was compared to Luciferase RNAi 
and BubR1 RNAi treated cells. Each circle represents a single cell analyzed 
(at least 50 cells were analyzed per condition) and the red line indicates the 
median (m=). A Mann Whitney test was used for statistical analysis. B) Still 
images from the time-lapse movies of Venus-BubR1 and Venus-BubR1 Δ490-
560. Scale bar represents 10 μm. C) Similar to A) but cells was challenged 
with either 200 nM taxol or 100 nM nocodazole as indicated. The red line 
indicates the median (m=) and each circle represents a single cell analyzed 
(at least 50 cells were analyzed per condition). A Mann Whitney test was used 
for statistical analysis. D) The indicated Venus-BubR1 proteins were purified 
from taxol arrested cells using a GFP affinity resin and washed with different 
salt conditions, as indicated. The binding to the indicated proteins was 
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analyzed by western blotting. E) HeLa cells stably expressing similar levels of 
Venus-BubR1, Venus-BubR1 ΔBub3 or Venus-BubR1 ΔBub3/Δ490-560 and 
depleted of endogenous BubR1 were treated with 200 nM taxol and their 
mitotic progression was followed by time-lapse microscopy. Each circle 
represents a single cell analyzed (at least 40 cells were analyzed per 
condition) and the red bars indicate the medians (m=). A Mann Whitney test 
was used for statistical analysis. F) HeLa cells were depleted of BubR1 and/or 
p31comet as indicated. Luciferase knock down was included as control. BubR1 
depletion was complemented with Venus-BubR1 or Venus-BubR1 Δ490-560 
as indicated and 200 nM taxol was added prior filming. Each circle represents 
a single cell analyzed and at least 50 cells were analyzed per condition. 
Medians (m=) are shown in red and a Mann Whitney test was used for the 
statistical analysis. 
 
Figure 5. The IC20BD is required for SAC silencing.   
 A) Stable HeLa cells were depleted of endogenous BubR1 or treated with 
control RNAi oligo (Luciferase). BubR1 knock down was complemented by 
expression of Venus-BubR1, Venus-BubR1 ΔBub3 or Venus-BubR1 
ΔBub3/Δ490-560 as indicated and mitotic progression was followed by time-
lapse microscopy. Each circle represents a single cell analyzed (at least 40 
cells were analyzed for each condition) and the median (m=) is shown as a 
red bar. Statistical analysis was performed using a Mann Whitney test. B) 
Stable HeLa cell lines were depleted of endogenous BubR1 and 
complemented by expression of Venus-BubR1 or Venus-BubR1 Δ490-560 as 
indicated. Cells were arrested in mitosis with 100 nM nocodazole prior filming 
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and subsequently treated with 0.5 μM reversine to silence the SAC. Each 
circle represents a single cell analyzed and at least 120 cells were analyzed 
per condition. Red bars indicate means (m=) and a t-test was used for 
statistical analysis. C) Representative still images from B. Scale bar 
represents 10 μm. D-E) Venus-Cdc20 was purified from a stable HeLa cell 
line arrested in mitosis with nocodazole. The beads were incubated with 
increasing concentrations of recombinant FLAG-HA-BubR1 516-715 at room 
temperature for 1 hour and afterwards washed. The binding of endogenous 
BubR1 and Mad2 to Venus-Cdc20 was analyzed by western blot analysis and 
quantified using Licor technology. Representative of two independent 
experiments. F) HeLa cells were transfected with the indicated BubR1 
constructs and before filming 200 nM taxol was added. The time from NEBD 
to mitotic exit was measured by analyzing the time-lapse movies and at least 
50 cells were analyzed per condition. Medians (m=) are shown as red bars 
and a Mann-Whitney test was used for statistical analysis. 
 
Figure 6. Dual role of the IC20BD in regulating the SAC. 
 At the kinetochore the IC20BD recruits Cdc20 to facilitate its interaction with 
Mad2 and potentially the formation of a partly assembled MCC. In the 
cytoplasm the IC20BD contributes to SAC silencing likely by competing for 
binding to Cdc20 with the N-terminal Mad3 homology region of BubR1. These 
two opposing activities of the IC20BD could make the SAC more dynamic and 
also couples MCC production or disassembly to BubR1 localization. 
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